ArticleJHEP reports : innovation in hepatology2025

The weight of choices: Prioritizing lifestyle over GLP-1 receptor agonist therapy in managing MASLD.

Jörn M Schattenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.